These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 38878516)

  • 1. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.
    Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y
    Eur J Med Chem; 2024 Sep; 275():116589. PubMed ID: 38878516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unveiling anti-diabetic potential of new thiazole-sulfonamide derivatives: Design, synthesis, in vitro bio-evaluation targeting DPP-4, α-glucosidase, and α-amylase with in-silico ADMET and docking simulation.
    Khamees Thabet H; Ammar YA; Imran M; Hamdy Helal M; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Abusaif MS; Ragab A
    Bioorg Chem; 2024 Oct; 151():107671. PubMed ID: 39067419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel 6-(piperidin-1-ylsulfonyl)-2H-chromenes targeting α-glucosidase, α-amylase, and PPAR-γ: Design, synthesis, virtual screening, and anti-diabetic activity for type 2 diabetes mellitus.
    Thabet HK; Abusaif MS; Imran M; Helal MH; Alaqel SI; Alshehri A; Mohd AA; Ammar YA; Ragab A
    Comput Biol Chem; 2024 Aug; 111():108097. PubMed ID: 38772048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-γ Agonists, α-Glucosidase, α-Amylase and COX-2 inhibitors; Design, synthesis and in silico study.
    Fadaly WAA; Elshewy A; Nemr MTM; Abdou K; Sayed AM; Kahk NM
    Bioorg Chem; 2024 Nov; 152():107760. PubMed ID: 39197383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation.
    Luo S; Zhao L; Peng H; Peng Z; Wang G
    Eur J Med Chem; 2024 Sep; 275():116600. PubMed ID: 38889608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel acyl hydrazide derivatives of polyhydroquinoline as potent anti-diabetic and anti-glycating agents: Synthesis, in vitro α-amylase, α-glucosidase inhibition and anti-glycating activity with molecular docking insights.
    Ur Rahman S; Alam A; Parveen Z; Zainab ; Assad M; Adnan Ali Shah S; Rafiq H; Ayaz M; Latif A; Naveed Umar M; Ali M; Ahmad M
    Bioorg Chem; 2024 Sep; 150():107501. PubMed ID: 38865858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation.
    Ragab A; Salem MA; Ammar YA; Aboulthana WM; Helal MH; Abusaif MS
    Drug Dev Res; 2024 Jun; 85(4):e22216. PubMed ID: 38831547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing benzenesulfonamide-thiazolidinone hybrids as multitarget directed ligands for efficient control of type 2 diabetes mellitus through targeting the enzymes: α-glucosidase and carbonic anhydrase II.
    Gamal MA; Fahim SH; Giovannuzzi S; Fouad MA; Bonardi A; Gratteri P; Supuran CT; Hassan GS
    Eur J Med Chem; 2024 May; 271():116434. PubMed ID: 38653067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
    Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
    Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting
    Gohar NA; Fayed EA; A Ammar Y; A Abu Ali O; Ragab A; Mahfoz AM; Abusaif MS
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2367128. PubMed ID: 38913598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.
    Gummidi L; Kerru N; Ebenezer O; Awolade P; Sanni O; Islam MS; Singh P
    Bioorg Chem; 2021 Oct; 115():105210. PubMed ID: 34332231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of piperazine sulfonamide analogs as diabetic-II inhibitors and their molecular docking study.
    Taha M; Irshad M; Imran S; Chigurupati S; Selvaraj M; Rahim F; Ismail NH; Nawaz F; Khan KM
    Eur J Med Chem; 2017 Dec; 141():530-537. PubMed ID: 29102178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cinnamic acid magnolol derivatives as potent α-glucosidase and α-amylase inhibitors: Synthesis, in vitro and in silico studies.
    Hu CM; Wang WJ; Ye YN; Kang Y; Lin J; Wu PP; Li DL; Bai LP; Xu XT; Li BQ; Zhang K
    Bioorg Chem; 2021 Nov; 116():105291. PubMed ID: 34438122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study.
    Ghannay S; Snoussi M; Messaoudi S; Kadri A; Aouadi K
    Bioorg Chem; 2020 Nov; 104():104270. PubMed ID: 32947132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and docking of indole sulfonamide as a potent inhibitor of α-glucosidase enzyme in streptozotocin -induced diabetic albino wistar rats.
    Taha M; Imran S; Salahuddin M; Iqbal N; Rahim F; Uddin N; Shehzad A; Khalid Farooq R; Alomari M; Mohammed Khan K
    Bioorg Chem; 2021 May; 110():104808. PubMed ID: 33756236
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose.
    Cardullo N; Floresta G; Rescifina A; Muccilli V; Tringali C
    Bioorg Chem; 2021 Dec; 117():105458. PubMed ID: 34736132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
    Zahra S; Zaib S; Khan I
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile synthesis and
    Punia R; Mor S; Khatri M; Kumar D; Das PP; Jindal DK; Kumar A; Selvaraj P; Kumar R; Mohil R; Jakhar K
    Future Med Chem; 2024; 16(10):999-1027. PubMed ID: 38910576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.